5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Netherlands In Vitro Diagnostics Market is segmented by Technology (Clinical Chemistry, Immunoassays, Hematology, Coagulation and Hemostasis, Microbiology, Point-of-Care Diagnostics, and Molecular Diagnostics), Product, Usability, and End User
The Netherlands in vitro diagnostics market is expected to register a CAGR of approximately 5.28% over the forecast period. The major factors that are fueling this market include rapid increase in chronic diseases, increasing demand for point-of-care testing and personalized medicine, and technological advances, along with the rising geriatric population in the country.
As per a report of National Institute of Health (NIH), incidences and prevalence of chronic diseases are rapidly increasing across the world and are currently affecting more than 14 million people around the world. Furthermore, according to the World Health Organization, the prevalence rate of the overweight population in the Netherlands was 67% for men and 59% for women in 2016, and this rate is expected to increase in the coming years.
According to the European Diagnostic Manufacturers Association (EDMA), the cost of IVDs to the European healthcare systems is less than EUR 21 per person per year. In addition, patients can deal with their conditions better with the help of IVDs (diabetic patients can use portable blood glucose monitors on a regular basis to determine their blood glucose level). Therefore, the demand for IVD products is influenced by the increase in incidences of chronic diseases. As the demand for IVD is increasing, the market is growing at a faster pace.
As per the scope of this report, in vitro diagnostics involves medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as Diabetes and Cancer.
|By Test Type|
|Disposable IVD Devices|
|Reusable IVD Devices|
|By End User|
|Hospitals & Clinics|
|Other End Users|
Report scope can be customized per your requirements. Click here.
Molecular diagnostic devices are used to analyze biological markers in the genome and proteome to detect pathogens or mutations. On the basis of technology used, molecular diagnostic devices can be segmented into chips and microarrays, mass spectroscopy, next-generation sequencing (NGS), polymerase chain reaction (PCR)-based methods, cytogenetics, and molecular imaging.
Factors, such as large outbreaks of bacterial and viral epidemics in the Netherlands, increasing demand for point-of-care diagnostics, and rapidly evolving technology, are driving the growth of the molecular diagnostics segment.
To understand key trends, Download Sample Report
The Netherlands in vitro diagnostics market is moderately competitive with several key players, such as Roche Diagnostics, Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, and Thermo Fisher Scientific Inc., which holds a large shares of this market. However, with the help of product innovation and technological advances, there is a possibility of new players entering the market in the future.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Increase in Chronic Diseases
4.2.2 Increasing Number of Private Hospitals and Independent Testing Laboratories
4.2.3 Increasing Demand for Point-of-Care Testing and Personalized Medicine
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Test Type
5.1.1 Clinical Chemistry
5.1.2 Molecular Diagnostics
5.1.3 Immuno Diagnostics
5.1.5 Other Types
5.2 By Product
5.2.3 Other Products
5.3 By Usability
5.3.1 Disposable IVD Devices
5.3.2 Reusable IVD Devices
5.4 By Application
5.4.1 Infectious Disease
5.4.6 Other Applications
5.5 By End User
5.5.1 Diagnostic Laboratories
5.5.2 Hospitals & Clinics
5.5.3 Other End Users
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Becton, Dickinson and Company
6.1.3 Bio-Rad Laboratories Inc.
6.1.4 Danaher Corporation
6.1.5 Johnson & Johnson
6.1.6 Roche Diagnostics
6.1.7 Siemens Healthcare
6.1.8 Thermo Fisher Scientific Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments